Application Note: In-depth peptide mapping with iterative MS/MS acquisition on the Agilent 6545XT AdvanceBio LC/Q TOF
28 June 2021

Therapeutic monoclonal antibodies (mAbs) represent one of the fastest growing classes of protein-based drugs in the biopharmaceutical industry. Here, Agilent Technologies presents an integrated workflow for peptide mapping of a mAb, from automated sample preparation to data analysis, featuring an Agilent AssayMAP Bravo liquid-handling robot, the Agilent 1290 Infinity II LC system, the Agilent 6545XT AdvanceBio Q-TOF, and the Agilent MassHunter BioConfirm B.09 software.